David Shaw’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,251,830
| Closed | -$7.31M | – | 4834 |
|
|
2025
Q1 | $7.31M | Sell |
1,251,830
-551,702
| -31% | -$2.91M | 0.01% | 1630 |
|
|
2024
Q4 | $6.71M | Buy |
1,803,532
+256,943
| +17% | +$1.19M | ﹤0.01% | 1763 |
|
|
2024
Q3 | $8.65M | Buy |
1,546,589
+400,359
| +35% | +$2.8M | 0.01% | 1520 |
|
|
2024
Q2 | $9.65M | Sell |
1,146,230
-7,508
| -0.7% | -$80.1K | 0.01% | 1354 |
|
|
2024
Q1 | $16.7M | Sell |
1,153,738
-49,246
| -4% | -$814K | 0.01% | 1029 |
|
|
2023
Q4 | $25.9M | Buy |
1,202,984
+69,835
| +6% | +$1.25M | 0.02% | 782 |
|
|
2023
Q3 | $21.8M | Buy |
1,133,149
+62,170
| +6% | +$1.33M | 0.02% | 795 |
|
|
2023
Q2 | $27.2M | Buy |
1,070,979
+268,384
| +33% | +$7.75M | 0.03% | 711 |
|
|
2023
Q1 | $29M | Buy |
802,595
+209,296
| +35% | +$7.35M | 0.03% | 685 |
|
|
2022
Q4 | $23.5M | Buy |
593,299
+250,090
| +73% | +$10.4M | 0.03% | 822 |
|
|
2022
Q3 | $16M | Sell |
343,209
-12,382
| -3% | -$575K | 0.02% | 1001 |
|
|
2022
Q2 | $15.6M | Sell |
355,591
-27,378
| -7% | -$1.51M | 0.02% | 1056 |
|
|
2022
Q1 | $27.7M | Buy |
382,969
+133,892
| +54% | +$9.65M | 0.03% | 827 |
|
|
2021
Q4 | $20.2M | Sell |
249,077
-113,705
| -31% | -$11.4M | 0.02% | 1084 |
|
|
2021
Q3 | $42.2M | Sell |
362,782
-241,217
| -40% | -$31.6M | 0.04% | 611 |
|
|
2021
Q2 | $100M | Sell |
603,999
-158,058
| -21% | -$24.7M | 0.09% | 264 |
|
|
2021
Q1 | $106M | Sell |
762,057
-337,393
| -31% | -$55.1M | 0.1% | 227 |
|
|
2020
Q4 | $190M | Sell |
1,099,450
-157,327
| -13% | -$25.5M | 0.17% | 109 |
|
|
2020
Q3 | $175M | Sell |
1,256,777
-4,477
| -0.4% | -$598K | 0.18% | 106 |
|
|
2020
Q2 | $151M | Sell |
1,261,254
-233,660
| -16% | -$27.7M | 0.18% | 103 |
|
|
2020
Q1 | $149M | Sell |
1,494,914
-437,604
| -23% | -$52.6M | 0.23% | 81 |
|
|
2019
Q4 | $227M | Sell |
1,932,518
-171,876
| -8% | -$17M | 0.26% | 69 |
|
|
2019
Q3 | $181M | Buy |
2,104,394
+36,994
| +2% | +$2.8M | 0.22% | 77 |
|
|
2019
Q2 | $134M | Buy |
2,067,400
+216,680
| +12% | +$13.5M | 0.17% | 130 |
|
|
2019
Q1 | $116M | Buy |
1,850,720
+534,630
| +41% | +$25.1M | 0.15% | 153 |
|
|
2018
Q4 | $51.2M | Buy |
1,316,090
+911,332
| +225% | +$40.5M | 0.07% | 337 |
|
|
2018
Q3 | $23.1M | Buy |
404,758
+360,065
| +806% | +$22.5M | 0.03% | 702 |
|
|
2018
Q2 | $3.57M | Buy |
44,693
+40,521
| +971% | +$3.36M | ﹤0.01% | 1773 |
|
|
2018
Q1 | $362K | Buy |
+4,172
| New | +$337K | ﹤0.01% | 3052 |
|
|
2017
Q2 | – | Sell |
-2,689
| Closed | -$252K | – | 3576 |
|
|
2017
Q1 | $252K | Buy |
+2,689
| New | +$244K | ﹤0.01% | 3039 |
|
|
2016
Q4 | – | Sell |
-8,392
| Closed | -$876K | – | 3640 |
|
|
2016
Q3 | $876K | Buy |
+8,392
| New | +$758K | ﹤0.01% | 2468 |
|
|
2016
Q2 | – | Sell |
-3,600
| Closed | -$203K | – | 3570 |
|
|
2016
Q1 | $203K | Sell |
3,600
-400
| -10% | -$23.6K | ﹤0.01% | 3181 |
|
|
2015
Q4 | $270K | Sell |
4,000
-9,985
| -71% | -$535K | ﹤0.01% | 3430 |
|
|
2015
Q3 | $649K | Buy |
13,985
+1,877
| +16% | +$90.9K | ﹤0.01% | 2894 |
|
|
2015
Q2 | $651K | Buy |
+12,108
| New | +$617K | ﹤0.01% | 3003 |
|
Other funds holding NVRO
David Shaw's NVRO Position: Q2 2025 in Review
David Shaw sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 1,251,830 shares — an estimated $7.31M sold.
David Shaw first reported a position in NVRO in Q2 2015 and held it in 35 quarters. The position peaked at $227M in Q4 2019. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- David Shaw reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- David Shaw sold 1,251,830 NEVRO CORP. shares in Q2 2025, an estimated $7.31M.
- David Shaw first reported a position in NEVRO CORP. in Q2 2015 and held it in 35 quarters.
- David Shaw's NEVRO CORP. position peaked at $227M in Q4 2019.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.